JP2007521294A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007521294A5 JP2007521294A5 JP2006518692A JP2006518692A JP2007521294A5 JP 2007521294 A5 JP2007521294 A5 JP 2007521294A5 JP 2006518692 A JP2006518692 A JP 2006518692A JP 2006518692 A JP2006518692 A JP 2006518692A JP 2007521294 A5 JP2007521294 A5 JP 2007521294A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- agent
- size
- biocompatiblely
- bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/611,723 US7041287B2 (en) | 1998-05-21 | 2003-07-01 | Compositions and methods for selective dissolution of nascent intravascular blood clots |
| PCT/US2004/020660 WO2005004804A2 (en) | 2003-07-01 | 2004-06-28 | Compositions and methods for selective dissolution of nascent intravascular blood clots |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007521294A JP2007521294A (ja) | 2007-08-02 |
| JP2007521294A5 true JP2007521294A5 (https=) | 2007-09-13 |
Family
ID=34062346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006518692A Pending JP2007521294A (ja) | 2003-07-01 | 2004-06-28 | 初期血管内凝血を選択的に分解する組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7041287B2 (https=) |
| EP (1) | EP1648497A2 (https=) |
| JP (1) | JP2007521294A (https=) |
| AU (1) | AU2004255196B2 (https=) |
| CA (1) | CA2530529A1 (https=) |
| WO (1) | WO2005004804A2 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1093378A4 (en) * | 1998-05-21 | 2001-10-10 | Univ Pennsylvania | COMPOSITIONS AND TECHNIQUES FOR PREVENTING AND TREATING ANARCHIC FORMATION OF INTRAVASCULAR FIBRINOUS CLOTS |
| US7674466B2 (en) * | 1999-08-05 | 2010-03-09 | The Trustees Of The University Of Pennsylvania | Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells using antibodies that bind to ICAM-1 |
| AU4155602A (en) * | 2000-11-01 | 2002-06-18 | Elusys Therapeutics Inc | Method of producing biospecific molecules by protein trans-splicing |
| US20070003552A1 (en) * | 2002-07-09 | 2007-01-04 | Gebbink Martijn F B | Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation |
| EP1380290A1 (en) | 2002-07-09 | 2004-01-14 | Universitair Medisch Centrum Utrecht | Cross-beta structure pathway and its therapeutic relevance |
| US20080317761A1 (en) * | 2004-04-28 | 2008-12-25 | The Trustees Of The University Of Pennsylvania | Peptide-Mediated Protein Transduction Into Cells of the Hematopoietic Lineage |
| EP1814914A2 (en) * | 2004-10-29 | 2007-08-08 | The Regents of the University of Colorado | Antibodies that bind urokinase-type plasminogen activator and epitopes therefor |
| US20090202980A1 (en) * | 2005-03-21 | 2009-08-13 | Crossbeta Biosciences B.V. | Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation |
| US8114832B2 (en) * | 2005-07-13 | 2012-02-14 | Crossbeta Biosciences B.V. | Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition |
| CA2615078A1 (en) * | 2005-07-13 | 2007-01-18 | Crossbeta Biosciences B.V. | Methods for determining the effect of a treatment on the cross-.beta. structure content of a protein; selection of treatments and uses thereof |
| CA2615028A1 (en) * | 2005-07-13 | 2007-01-18 | Crossbeta Biosciences B.V. | Cross-.beta. structure binding compounds |
| WO2008039206A2 (en) * | 2005-10-05 | 2008-04-03 | The Trustees Of The University Of Pennsylvania | Fusion proteins for inhibition and dissolution of coagulation |
| CA2645930A1 (en) * | 2006-03-17 | 2007-09-27 | Crossbeta Biosciences B.V. | Methods of binding of cross-beta structures by chaperones |
| WO2008147526A1 (en) * | 2007-05-23 | 2008-12-04 | The Trustees Of The University Of Pennsylvania | Targeted carriers for intracellular drug delivery |
| EP2058001A1 (en) * | 2007-11-08 | 2009-05-13 | Crossbeta Biosciences B.V. | Enhancement of immunogenicity of antigens |
| EP2058000A1 (en) * | 2007-11-08 | 2009-05-13 | Crossbeta Biosciences B.V. | Immunogenic compositions capable of activating T cells |
| US8333973B2 (en) * | 2008-01-02 | 2012-12-18 | The Trustees Of The University Of Pennsylvania | Targeting recombinant therapeutics to circulating red blood cells |
| US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| WO2012021512A2 (en) | 2010-08-10 | 2012-02-16 | Ecole Polytechnique Federale De Lausanne | Erythrocyte-binding therapeutics |
| WO2014153394A1 (en) | 2013-03-21 | 2014-09-25 | Genisphere, Llc | Cellular delivery of dna intercalating agents |
| KR102717969B1 (ko) | 2014-02-21 | 2024-10-15 | 에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘) | 글리코타겟팅 치료제 |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| IL260983B (en) | 2016-02-19 | 2022-07-01 | Genisphere Llc | Nucleic acid carriers and methods of medical use |
| US11253579B2 (en) | 2017-06-16 | 2022-02-22 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| EA202092723A1 (ru) | 2018-05-09 | 2021-04-09 | Зе Юниверсити Оф Чикаго | Композиции и способы, касающиеся иммунной толерантности |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60200169A (ja) * | 1984-03-23 | 1985-10-09 | Green Cross Corp:The | 線維素溶解酵素前駆体測定用試薬 |
| EP1093378A4 (en) * | 1998-05-21 | 2001-10-10 | Univ Pennsylvania | COMPOSITIONS AND TECHNIQUES FOR PREVENTING AND TREATING ANARCHIC FORMATION OF INTRAVASCULAR FIBRINOUS CLOTS |
-
2003
- 2003-07-01 US US10/611,723 patent/US7041287B2/en not_active Expired - Lifetime
-
2004
- 2004-06-28 CA CA002530529A patent/CA2530529A1/en not_active Abandoned
- 2004-06-28 WO PCT/US2004/020660 patent/WO2005004804A2/en not_active Ceased
- 2004-06-28 EP EP04777178A patent/EP1648497A2/en not_active Withdrawn
- 2004-06-28 JP JP2006518692A patent/JP2007521294A/ja active Pending
- 2004-06-28 AU AU2004255196A patent/AU2004255196B2/en not_active Ceased
-
2006
- 2006-02-13 US US11/352,720 patent/US20060140917A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007521294A5 (https=) | ||
| US20230000911A1 (en) | Human blood-derived products having decreased fibrinolytic activity and uses thereof in hemostatic disorders | |
| DK175704B1 (da) | Inhibering af arteriel thrombotisk okklusion eller thromboenboli | |
| Smith et al. | How it all starts: Initiation of the clotting cascade | |
| FISCHER | Essentials of anticoagulation in hemodialysis | |
| RU2705786C2 (ru) | Gla домены в качестве терапевтических агентов | |
| Gorbet et al. | Leukocyte activation and leukocyte procoagulant activities after blood contact with polystyrene and polyethylene glycol–immobilized polystyrene beads | |
| WO2009086552A1 (en) | Targeting recombinant therapeutics to circulating red blood cells | |
| Kalathottukaren et al. | Mechanisms of blood coagulation in response to biomaterials: Extrinsic factors | |
| Esmon | 2 Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis | |
| CA3089175A1 (en) | Extracorporeal device and matrix for removing fibrinolytic proteins from biological fluids, methods and uses thereof | |
| Hoang et al. | Impact of tissue factor expression and administration routes on thrombosis development induced by mesenchymal stem/stromal cell infusions: re-evaluating the dogma | |
| Ali et al. | The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease | |
| EP1128842B1 (en) | Use of human protein c for the manufacture of a medicament for treating heparin-induced thrombocytopenia | |
| Lin et al. | A cysteine enzyme hemostat for efficient heparin-tolerant blood coagulation | |
| Nellenbach et al. | Peptide mimetic drugs for modulating thrombosis and hemostasis | |
| RU2013152864A (ru) | Высокоселективный ингибитор контактной активации на основе инфестина 4 | |
| ES2532978T3 (es) | Especialidades farmacéuticas para el tratamiento de trastornos de coagulación de la sangre que contienen concentrado de factor XIa sin trombina | |
| CN119684441B (zh) | 一种衍生多肽pm6及其在抗血栓中的应用 | |
| Liang et al. | ADVANCES IN PHARMACOLOGICAL EFFECTS OF ANTITHROMBOLYTIC DRUGS | |
| JP2016536368A5 (https=) | ||
| Kalathottukaren et al. | University of British Columbia, Vancouver, BC, Canada | |
| Cerenzia | β3 Integrin PSI Domain Thiol Isomerase Activity: A Novel Role in Blood Coagulation & Implications of the L33P Polymorphism | |
| CN114681597A (zh) | 蝰蛇蛇毒血凝酶在制备用于逆转凝血因子Xa抑制剂的抗凝作用的药物中的应用 | |
| Chang et al. | Hemostasis and the effect of cardiopulmonary bypass on hemostasis |